PD-1 Primarily Targets TCR Signal in the Inhibition of Functional T Cell Activation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PD-1 Primarily Targets TCR Signal in the Inhibition of Functional T Cell Activation

Published:2019-03-29 Issue: Volume:10 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Mizuno Reina,Sugiura Daisuke,Shimizu Kenji,Maruhashi Takumi,Watada Mizuki,Okazaki Il-mi,Okazaki Taku

Funder

Japan Science and Technology Agency

Japan Agency for Medical Research and Development

Japan Society for the Promotion of Science

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference53 articles.

1. Coinhibitory pathways in the B7-CD28 ligand-receptor family;Schildberg;Immunity.,2016

2. A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application;Okazaki;Nat Immunol.,2013

3. CD28 Costimulation: from mechanism to therapy;Esensten;Immunity.,2016

4. PD-1 and PD-1 ligands: from discovery to clinical application;Okazaki;Int Immunol.,2007

5. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice;Nishimura;Science.,2001

Cited by 116 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cis-interaction between CD52 and T cell receptor complex interferes with CD4+ T cell activation in acute decompensation of cirrhosis;eBioMedicine;2024-10

2. Immune effects of α and β radionuclides in metastatic prostate cancer;Nature Reviews Urology;2024-08-27

3. Mature tertiary lymphoid structures: important contributors to anti-tumor immune efficacy;Frontiers in Immunology;2024-07-04

4. Identification of Hypoxia‐ALCAM^high Macrophage‐ Exhausted T Cell Axis in Tumor Microenvironment Remodeling for Immunotherapy Resistance;Advanced Science;2024-07-02

5. Inhibitory immune checkpoints suppress the surveillance of senescent cells promoting their accumulation with aging and in age-related diseases;Biogerontology;2024-07-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3